Investigation Overview
January 27, 2014 (Shareholders Foundation) - An investigation on behalf of investors of Immunomedics, Inc. (NASDAQ:IMMU) shares over potential securities laws violations by Immunomedics and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities...
You must register (for free) or login to view the entire investigation.